0 XP   0   0   0

Asian Phytoceuticals Public Company Limited










Financial Health of Asian Phytoceuticals Public Company Limited




Comparing to competitors in the Household & Personal Products industry




  Industry Rankings  


Richest
#166 / 198

Total Sales
#162 / 198

Making Money
#119 / 198

Working Efficiently
#3 / 198

Asian Phytoceuticals Public Company Limited
Buy, Hold or Sell?

Should you buy, hold or sell Asian Phytoceuticals Public Company Limited?

I guess you are interested in Asian Phytoceuticals Public Company Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Asian Phytoceuticals Public Company Limited

Let's start. I'm going to help you getting a better view of Asian Phytoceuticals Public Company Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Asian Phytoceuticals Public Company Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Asian Phytoceuticals Public Company Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Asian Phytoceuticals Public Company Limited. The closing price on 2022-12-01 was ฿4.7 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Asian Phytoceuticals Public Company Limited Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Asian Phytoceuticals Public Company Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Asian Phytoceuticals Public Company Limited earns for each ฿1 of revenue.

  • Above 10% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
  • A Net Profit Margin of 33.3% means that ฿0.33 for each ฿1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 33.3%. The company is making a huge profit. +2
  • The TTM is 31.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.3%TTM31.2%+2.1%
TTM31.2%YOY28.0%+3.2%
TTM31.2%5Y27.7%+3.5%
5Y27.7%10Y26.7%+1.0%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ33.3%3.8%+29.5%
TTM31.2%3.3%+27.9%
YOY28.0%5.2%+22.8%
5Y27.7%4.1%+23.6%
10Y26.7%4.7%+22.0%
1.1.2. Return on Assets

Shows how efficient Asian Phytoceuticals Public Company Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
  • 3.3% Return on Assets means that Asian Phytoceuticals Public Company Limited generated ฿0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 3.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.3%TTM2.8%+0.4%
TTM2.8%YOY2.4%+0.4%
TTM2.8%5Y2.9%0.0%
5Y2.9%10Y3.8%-0.9%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%0.9%+2.4%
TTM2.8%0.9%+1.9%
YOY2.4%1.3%+1.1%
5Y2.9%1.1%+1.8%
10Y3.8%1.3%+2.5%
1.1.3. Return on Equity

Shows how efficient Asian Phytoceuticals Public Company Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
  • 3.6% Return on Equity means Asian Phytoceuticals Public Company Limited generated ฿0.04 for each ฿1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 3.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM3.2%+0.4%
TTM3.2%YOY2.8%+0.4%
TTM3.2%5Y3.2%+0.0%
5Y3.2%10Y4.3%-1.1%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%2.1%+1.5%
TTM3.2%1.9%+1.3%
YOY2.8%3.0%-0.2%
5Y3.2%2.2%+1.0%
10Y4.3%2.5%+1.8%

1.2. Operating Efficiency of Asian Phytoceuticals Public Company Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Asian Phytoceuticals Public Company Limited is operating .

  • Measures how much profit Asian Phytoceuticals Public Company Limited makes for each ฿1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
  • An Operating Margin of 36.7% means the company generated ฿0.37  for each ฿1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 36.7%. The company is operating very efficient. +2
  • The TTM is 34.6%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ36.7%TTM34.6%+2.1%
TTM34.6%YOY29.0%+5.7%
TTM34.6%5Y32.1%+2.5%
5Y32.1%10Y18.9%+13.2%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ36.7%4.5%+32.2%
TTM34.6%3.5%+31.1%
YOY29.0%6.1%+22.9%
5Y32.1%5.9%+26.2%
10Y18.9%6.0%+12.9%
1.2.2. Operating Ratio

Measures how efficient Asian Phytoceuticals Public Company Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • An Operation Ratio of 0.82 means that the operating costs are ฿0.82 for each ฿1 in net sales.

Let's take a look of the Operating Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 0.823. The company is less efficient in keeping operating costs low.
  • The TTM is 0.848. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.823TTM0.848-0.025
TTM0.848YOY0.925-0.076
TTM0.8485Y0.891-0.043
5Y0.89110Y0.581+0.310
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8231.314-0.491
TTM0.8481.207-0.359
YOY0.9251.046-0.121
5Y0.8910.986-0.095
10Y0.5810.935-0.354

1.3. Liquidity of Asian Phytoceuticals Public Company Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Asian Phytoceuticals Public Company Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Household & Personal Products industry mean).
  • A Current Ratio of 6.23 means the company has ฿6.23 in assets for each ฿1 in short-term debts.

Let's take a look of the Current Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 6.227. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.431. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.227TTM5.431+0.797
TTM5.431YOY5.222+0.209
TTM5.4315Y10.710-5.280
5Y10.71010Y6.700+4.010
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2271.634+4.593
TTM5.4311.569+3.862
YOY5.2221.643+3.579
5Y10.7101.661+9.049
10Y6.7001.442+5.258
1.3.2. Quick Ratio

Measures if Asian Phytoceuticals Public Company Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
  • A Quick Ratio of 3.18 means the company can pay off ฿3.18 for each ฿1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 3.183. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.231. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.183TTM2.231+0.951
TTM2.231YOY1.963+0.268
TTM2.2315Y5.221-2.989
5Y5.22110Y3.429+1.792
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1830.658+2.525
TTM2.2310.655+1.576
YOY1.9630.732+1.231
5Y5.2210.721+4.500
10Y3.4290.674+2.755

1.4. Solvency of Asian Phytoceuticals Public Company Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Asian Phytoceuticals Public Company Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Asian Phytoceuticals Public Company Limited to Household & Personal Products industry mean.
  • A Debt to Asset Ratio of 0.10 means that Asian Phytoceuticals Public Company Limited assets are financed with 10.1% credit (debt) and the remaining percentage (100% - 10.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 0.101. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.114. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.101TTM0.114-0.013
TTM0.114YOY0.136-0.023
TTM0.1145Y0.099+0.014
5Y0.09910Y0.104-0.005
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1010.453-0.352
TTM0.1140.441-0.327
YOY0.1360.431-0.295
5Y0.0990.425-0.326
10Y0.1040.421-0.317
1.4.2. Debt to Equity Ratio

Measures if Asian Phytoceuticals Public Company Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
  • A Debt to Equity ratio of 11.3% means that company has ฿0.11 debt for each ฿1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 0.113. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.129. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.129-0.016
TTM0.129YOY0.158-0.029
TTM0.1295Y0.111+0.017
5Y0.11110Y0.120-0.009
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1130.819-0.706
TTM0.1290.782-0.653
YOY0.1580.720-0.562
5Y0.1110.747-0.636
10Y0.1200.759-0.639

2. Market Valuation of Asian Phytoceuticals Public Company Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ฿1 in earnings Asian Phytoceuticals Public Company Limited generates.

  • Above 15 is considered overpriced but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
  • A PE ratio of 137.06 means the investor is paying ฿137.06 for every ฿1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The EOD is 134.771. Seems overpriced? -1
  • The MRQ is 137.065. Seems overpriced? -1
  • The TTM is 172.554. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD134.771MRQ137.065-2.294
MRQ137.065TTM172.554-35.489
TTM172.554YOY179.050-6.496
TTM172.5545Y149.042+23.512
5Y149.04210Y162.831-13.789
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD134.77151.692+83.079
MRQ137.06555.784+81.281
TTM172.55456.960+115.594
YOY179.05073.878+105.172
5Y149.04251.010+98.032
10Y162.83142.705+120.126
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Asian Phytoceuticals Public Company Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The MRQ is 766.188. Seems overpriced? -1
  • The TTM is 832.982. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ766.188TTM832.982-66.795
TTM832.982YOY-35,181.855+36,014.837
TTM832.9825Y-11,204.816+12,037.798
5Y-11,204.81610Y-5,397.036-5,807.780
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ766.1880.205+765.983
TTM832.982-0.078+833.060
YOY-35,181.855-0.049-35,181.806
5Y-11,204.816-0.183-11,204.633
10Y-5,397.036-0.202-5,396.834

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Asian Phytoceuticals Public Company Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • A PB ratio of 4.97 means the investor is paying ฿4.97 for each ฿1 in book value.

Let's take a look of the Price to Book Ratio trends of Asian Phytoceuticals Public Company Limited:

  • The EOD is 4.889. Neutral. Compare to industry.
  • The MRQ is 4.972. Neutral. Compare to industry.
  • The TTM is 5.445. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4.889MRQ4.972-0.083
MRQ4.972TTM5.445-0.473
TTM5.445YOY4.601+0.844
TTM5.4455Y4.535+0.910
5Y4.53510Y6.675-2.141
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD4.8891.544+3.345
MRQ4.9721.792+3.180
TTM5.4451.997+3.448
YOY4.6012.211+2.390
5Y4.5351.942+2.593
10Y6.6751.861+4.814
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Asian Phytoceuticals Public Company Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0340.001+3175%0.002+1873%-0.002+105%0.009+273%
Book Value Growth--0.9720.971+0%0.971+0%0.971+0%0.971+0%
Book Value Per Share--0.9610.976-2%0.972-1%0.981-2%0.904+6%
Book Value Per Share Growth--0.035-0.001+102%0.000+7572%-0.004+111%0.007+375%
Current Ratio--6.2275.431+15%5.222+19%10.710-42%6.700-7%
Debt To Asset Ratio--0.1010.114-11%0.136-26%0.099+1%0.104-3%
Debt To Equity Ratio--0.1130.129-12%0.158-29%0.111+1%0.120-6%
Dividend Per Share---0.092-100%0.121-100%0.118-100%0.115-100%
Eps--0.0350.031+12%0.027+30%0.031+11%0.038-7%
Eps Growth--0.1790.000+56633%-0.075+142%-0.066+137%-0.047+126%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.3330.312+7%0.280+19%0.277+20%0.267+25%
Operating Margin--0.3670.346+6%0.290+27%0.321+14%0.189+94%
Operating Ratio--0.8230.848-3%0.925-11%0.891-8%0.581+42%
Pb Ratio4.889-2%4.9725.445-9%4.601+8%4.535+10%6.675-26%
Pe Ratio134.771-2%137.065172.554-21%179.050-23%149.042-8%162.831-16%
Peg Ratio--766.188832.982-8%-35181.855+4692%-11204.816+1562%-5397.036+804%
Price Per Share4.700-2%4.7805.318-10%4.460+7%4.456+7%5.900-19%
Price To Total Gains Ratio139.176-2%141.54599.664+42%51.135+177%73.393+93%65.851+115%
Profit Growth--97.65897.120+1%96.903+1%96.928+1%96.984+1%
Quick Ratio--3.1832.231+43%1.963+62%5.221-39%3.429-7%
Return On Assets--0.0330.028+15%0.024+36%0.029+13%0.038-14%
Return On Equity--0.0360.032+14%0.028+31%0.032+14%0.043-15%
Revenue Growth--0.9730.972+0%0.970+0%0.970+0%0.971+0%
Total Gains Per Share--0.0340.094-64%0.122-72%0.116-71%0.124-73%
Total Gains Per Share Growth--0.203-1.139+662%-0.500+347%-1.049+618%-0.909+548%
Usd Book Value--16611303.97416867065.744-2%16799487.214-1%16953165.151-2%15628505.656+6%
Usd Book Value Change Per Share--0.0010.000+3175%0.000+1873%0.000+105%0.000+273%
Usd Book Value Per Share--0.0280.028-2%0.028-1%0.028-2%0.026+6%
Usd Dividend Per Share---0.003-100%0.003-100%0.003-100%0.003-100%
Usd Eps--0.0010.001+12%0.001+30%0.001+11%0.001-7%
Usd Price Per Share0.135-2%0.1380.153-10%0.128+7%0.128+7%0.170-19%
Usd Profit--602623.843538467.962+12%463289.630+30%541572.993+11%648269.946-7%
Usd Revenue--1808102.0451715616.734+5%1639388.448+10%1977627.012-9%2429060.106-26%
Usd Total Gains Per Share--0.0010.003-64%0.004-72%0.003-71%0.004-73%
 EOD+3 -2MRQTTM+26 -8YOY+24 -105Y+19 -1510Y+19 -15

3.2. Fundamental Score

Let's check the fundamental score of Asian Phytoceuticals Public Company Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15134.771
Price to Book Ratio (EOD)Between0-14.889
Net Profit Margin (MRQ)Greater than00.333
Operating Margin (MRQ)Greater than00.367
Quick Ratio (MRQ)Greater than13.183
Current Ratio (MRQ)Greater than16.227
Debt to Asset Ratio (MRQ)Less than10.101
Debt to Equity Ratio (MRQ)Less than10.113
Return on Equity (MRQ)Greater than0.150.036
Return on Assets (MRQ)Greater than0.050.033
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Asian Phytoceuticals Public Company Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.660
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in THB. All numbers in thousands.

Summary
Total Assets641,478
Total Liabilities64,697
Total Stockholder Equity574,390
 As reported
Total Liabilities 64,697
Total Stockholder Equity+ 574,390
Total Assets = 641,478

Assets

Total Assets641,478
Total Current Assets249,555
Long-term Assets249,555
Total Current Assets
Cash And Cash Equivalents 63,721
Short-term Investments 123,809
Net Receivables 3,729
Inventory 56,851
Other Current Assets 355
Total Current Assets  (as reported)249,555
Total Current Assets  (calculated)248,465
+/- 1,089
Long-term Assets
Property Plant Equipment 69,554
Long Term Investments 308,905
Other Assets 13,199
Long-term Assets  (as reported)391,923
Long-term Assets  (calculated)391,658
+/- 266

Liabilities & Shareholders' Equity

Total Current Liabilities40,075
Long-term Liabilities24,622
Total Stockholder Equity574,390
Total Current Liabilities
Accounts payable 1,929
Other Current Liabilities 9,190
Total Current Liabilities  (as reported)40,075
Total Current Liabilities  (calculated)11,119
+/- 28,955
Long-term Liabilities
Other Liabilities 22,497
Long-term Liabilities  (as reported)24,622
Long-term Liabilities  (calculated)22,497
+/- 2,125
Total Stockholder Equity
Common Stock300,000
Retained Earnings 118,810
Total Stockholder Equity (as reported)574,390
Total Stockholder Equity (calculated)418,810
+/- 155,580
Other
Capital Stock300,000
Common Stock Shares Outstanding 600,000
Net Invested Capital 574,390
Net Tangible Assets 574,124
Net Working Capital 209,480



Balance Sheet

Currency in THB. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-03-312009-12-312008-12-312007-12-31
> Total Assets 
137,564
171,749
230,367
0
217,529
237,851
198,503
261,013
410,217
424,119
377,178
393,458
423,539
433,077
399,019
417,484
457,159
486,042
513,956
538,153
562,605
596,053
557,706
576,166
628,976
653,602
580,929
607,845
711,185
736,417
613,887
642,814
678,780
712,071
611,350
636,300
665,721
684,907
597,050
608,053
629,758
666,709
620,583
623,626
696,778
702,894
647,225
654,413
680,533
694,638
626,889
641,478
641,478626,889694,638680,533654,413647,225702,894696,778623,626620,583666,709629,758608,053597,050684,907665,721636,300611,350712,071678,780642,814613,887736,417711,185607,845580,929653,602628,976576,166557,706596,053562,605538,153513,956486,042457,159417,484399,019433,077423,539393,458377,178424,119410,217261,013198,503237,851217,5290230,367171,749137,564
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
595,591
621,894
502,930
534,848
573,627
609,830
510,555
538,283
569,416
590,475
504,910
519,191
544,522
571,136
322,664
277,482
240,717
268,650
217,091
205,677
231,112
273,021
212,802
249,555
249,555212,802273,021231,112205,677217,091268,650240,717277,482322,664571,136544,522519,191504,910590,475569,416538,283510,555609,830573,627534,848502,930621,894595,5910000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222,498
248,549
166,192
195,401
244,302
278,141
172,659
185,791
182,356
204,862
114,239
130,984
160,282
505,718
75,672
81,875
100,201
110,911
49,432
63,958
98,593
118,185
54,986
63,721
63,72154,986118,18598,59363,95849,432110,911100,20181,87575,672505,718160,282130,984114,239204,862182,356185,791172,659278,141244,302195,401166,192248,549222,4980000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
315,496
315,496
270,601
270,601
270,520
270,525
271,002
271,090
313,394
313,399
315,972
316,514
319,512
534
157,480
125,429
71,835
90,513
97,048
73,971
68,323
91,558
87,060
123,809
123,80987,06091,55868,32373,97197,04890,51371,835125,429157,480534319,512316,514315,972313,399313,394271,090271,002270,525270,520270,601270,601315,496315,4960000000000000000000000000000
       Net Receivables 
6,674
14,098
18,952
0
19,342
19,359
7,704
7,834
11,693
9,821
8,683
6,964
7,193
2,914
10,433
13,765
10,591
8,549
12,333
18,756
13,710
23,066
19,681
11,277
10,081
6,307
6,153
5,454
4,967
6,085
7,176
8,979
4,551
7,289
5,939
5,616
5,248
2,800
3,487
1,893
1,443
1,757
18,754
2,244
5,294
2,490
3,980
3,606
3,286
2,603
10,344
3,729
3,72910,3442,6033,2863,6063,9802,4905,2942,24418,7541,7571,4431,8933,4872,8005,2485,6165,9397,2894,5518,9797,1766,0854,9675,4546,1536,30710,08111,27719,68123,06613,71018,75612,3338,54910,59113,76510,4332,9147,1936,9648,6839,82111,6937,8347,70419,35919,342018,95214,0986,674
       Other Current Assets 
1,413
1,215
1,763
0
1,860
2,619
2,965
3,560
2,366
2,272
3,272
3,476
3,408
4,158
3,948
4,358
4,903
5,408
7,592
4,761
3,677
5,444
4,939
7,355
5,786
6,031
6,033
5,866
4,456
5,784
4,895
4,361
3,200
4,291
2,758
2,980
623
640
554
382
347
359
379
397
348
357
335
337
302
444
318
355
3553184443023373353573483973793593473825546406232,9802,7584,2913,2004,3614,8955,7844,4565,8666,0336,0315,7867,3554,9395,4443,6774,7617,5925,4084,9034,3583,9484,1583,4083,4763,2722,2722,3663,5602,9652,6191,86001,7631,2151,413
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,432
92,140
88,862
85,236
95,572
297,919
346,144
456,061
434,244
430,134
448,736
449,420
421,617
414,087
391,923
391,923414,087421,617449,420448,736430,134434,244456,061346,144297,91995,57285,23688,86292,14094,4320000000000000000000000000000000000000
       Property Plant Equipment 
54,932
60,378
60,196
0
60,129
58,982
71,206
72,282
71,075
82,248
81,840
82,112
88,079
87,675
86,015
84,661
91,509
88,043
90,371
93,607
105,743
146,654
151,537
150,415
146,682
142,697
138,570
134,896
106,712
104,019
100,562
97,190
93,772
90,546
88,517
85,274
83,607
81,176
78,014
74,654
71,355
80,517
73,157
67,940
113,390
105,907
101,628
95,535
91,208
80,495
75,109
69,554
69,55475,10980,49591,20895,535101,628105,907113,39067,94073,15780,51771,35574,65478,01481,17683,60785,27488,51790,54693,77297,190100,562104,019106,712134,896138,570142,697146,682150,415151,537146,654105,74393,60790,37188,04391,50984,66186,01587,67588,07982,11281,84082,24871,07572,28271,20658,98260,129060,19660,37854,932
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,533
1,392
1,398
1,925
2,244
2,450
2,794
2,819
3,197
3,345
3,453
3,609
3,701
214,385
265,521
331,928
317,986
317,221
341,409
346,733
330,416
327,305
308,905
308,905327,305330,416346,733341,409317,221317,986331,928265,521214,3853,7013,6093,4533,3453,1972,8192,7942,4502,2441,9251,3981,3921,53300000000000000000000000000000
       Intangible Assets 
0
0
469
0
409
437
431
503
523
632
601
570
575
552
520
488
479
454
429
404
1,343
1,384
1,335
1,284
1,234
1,185
1,137
1,097
1,129
1,090
1,051
1,011
972
933
894
854
815
776
737
698
658
0
0
0
503
0
0
0
356
0
0
0
0003560005030006586987377768158548949339721,0111,0511,0901,1291,0971,1371,1851,2341,2841,3351,3841,343404429454479488520552575570601632523503431437409046900
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,105
6,098
6,099
5,581
6,309
6,309
6,105
6,076
6,076
6,297
6,297
6,070
4,756
4,756
4,753
4,7534,7564,7566,0706,2976,2976,0766,0766,1056,3096,3095,5816,0996,0986,1050000000000000000000000000000000000000
> Total Liabilities 
15,837
29,947
52,756
0
31,602
45,923
44,053
36,100
38,604
40,094
32,257
34,048
46,195
42,162
41,049
38,055
52,883
133,285
50,598
40,479
47,561
174,435
47,835
44,964
60,797
60,554
54,318
48,299
62,084
63,189
48,628
46,017
50,468
58,611
47,193
47,054
51,558
55,401
48,802
44,935
50,567
70,331
59,438
53,426
101,314
96,247
90,379
80,107
85,538
80,285
70,370
64,697
64,69770,37080,28585,53880,10790,37996,247101,31453,42659,43870,33150,56744,93548,80255,40151,55847,05447,19358,61150,46846,01748,62863,18962,08448,29954,31860,55460,79744,96447,835174,43547,56140,47950,598133,28552,88338,05541,04942,16246,19534,04832,25740,09438,60436,10044,05345,92331,602052,75629,94715,837
   > Total Current Liabilities 
15,756
29,940
52,603
0
29,403
39,705
37,907
30,030
32,614
34,181
26,421
28,296
40,531
36,580
35,554
32,411
46,430
126,603
43,687
33,339
40,192
163,424
36,577
33,459
49,045
48,536
42,034
35,749
50,267
51,115
36,297
33,604
37,799
45,674
34,190
33,784
36,919
40,453
30,208
25,952
31,196
50,173
39,294
32,983
48,874
47,050
44,412
38,352
47,751
48,625
42,218
40,075
40,07542,21848,62547,75138,35244,41247,05048,87432,98339,29450,17331,19625,95230,20840,45336,91933,78434,19045,67437,79933,60436,29751,11550,26735,74942,03448,53649,04533,45936,577163,42440,19233,33943,687126,60346,43032,41135,55436,58040,53128,29626,42134,18132,61430,03037,90739,70529,403052,60329,94015,756
       Accounts payable 
788
869
3,062
0
2,117
3,806
1,722
1,705
1,638
2,183
1,853
2,555
1,177
2,437
2,546
2,451
1,963
3,603
2,499
3,796
1,387
2,096
1,418
2,193
1,863
1,017
1,721
1,948
1,745
2,648
2,118
1,921
1,548
2,289
1,229
4,530
1,735
629
1,818
785
690
3,196
3,062
1,686
631
648
1,432
853
1,992
1,311
1,392
1,929
1,9291,3921,3111,9928531,4326486311,6863,0623,1966907851,8186291,7354,5301,2292,2891,5481,9212,1182,6481,7451,9481,7211,0171,8632,1931,4182,0961,3873,7962,4993,6031,9632,4512,5462,4371,1772,5551,8532,1831,6381,7051,7223,8062,11703,062869788
       Other Current Liabilities 
4,883
20,899
41,390
0
26,395
34,996
35,298
27,453
30,119
31,154
23,719
24,873
38,469
33,241
32,088
28,580
43,999
123,000
41,188
29,543
38,806
161,329
35,159
31,266
47,183
47,519
40,312
33,801
48,522
48,466
34,178
31,684
36,251
43,385
14,082
9,324
16,047
2,110
1,913
1,880
11,155
16,300
12,256
8,986
12,950
15,535
11,806
7,127
13,233
18,416
13,709
9,190
9,19013,70918,41613,2337,12711,80615,53512,9508,98612,25616,30011,1551,8801,9132,11016,0479,32414,08243,38536,25131,68434,17848,46648,52233,80140,31247,51947,18331,26635,159161,32938,80629,54341,188123,00043,99928,58032,08833,24138,46924,87323,71931,15430,11927,45335,29834,99626,395041,39020,8994,883
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,948
18,595
18,983
19,371
20,158
20,144
20,443
52,440
49,197
45,967
41,755
37,787
31,660
28,152
24,622
24,62228,15231,66037,78741,75545,96749,19752,44020,44320,14420,15819,37118,98318,59514,9480000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
4,246
4,377
4,507
4,637
4,775
4,916
5,056
5,195
5,345
5,495
5,645
6,453
6,682
6,911
7,140
7,369
11,011
11,258
11,505
11,752
12,018
12,284
12,550
11,817
12,074
12,331
12,413
12,670
12,937
13,003
13,270
14,639
14,948
18,595
18,983
19,371
19,645
20,049
20,443
20,848
21,262
20,921
21,335
22,301
21,717
22,107
22,497
22,49722,10721,71722,30121,33520,92121,26220,84820,44320,04919,64519,37118,98318,59514,94814,63913,27013,00312,93712,67012,41312,33112,07411,81712,55012,28412,01811,75211,50511,25811,0117,3697,1406,9116,6826,4535,6455,4955,3455,1955,0564,9164,7754,6374,5074,3774,24600000
> Total Stockholder Equity
121,726
141,802
177,611
177,611
185,927
191,928
154,450
224,912
371,613
384,025
344,921
359,409
377,343
390,914
357,969
379,428
404,276
352,757
463,359
497,675
515,044
421,617
509,871
531,202
568,179
593,048
526,612
559,546
649,101
673,229
565,259
596,797
628,311
653,460
564,157
589,246
614,163
629,506
548,248
563,118
579,191
596,377
561,144
570,199
595,464
606,647
556,845
574,306
594,995
614,105
554,440
574,390
574,390554,440614,105594,995574,306556,845606,647595,464570,199561,144596,377579,191563,118548,248629,506614,163589,246564,157653,460628,311596,797565,259673,229649,101559,546526,612593,048568,179531,202509,871421,617515,044497,675463,359352,757404,276379,428357,969390,914377,343359,409344,921384,025371,613224,912154,450191,928185,927177,611177,611141,802121,726
   Common Stock
93,000
93,000
93,000
0
93,000
93,000
93,000
150,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
272,000
272,000
272,000
272,000
274,538
274,538
274,538
274,538
274,538
274,538
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000300,000274,538274,538274,538274,538274,538274,538272,000272,000272,000272,000200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000150,00093,00093,00093,000093,00093,00093,000
   Retained Earnings 
8,021
28,097
63,906
0
92,927
98,928
61,450
74,912
88,751
101,162
62,058
76,547
94,480
108,051
75,106
96,565
121,413
69,894
108,496
142,812
160,181
66,755
86,896
108,227
145,204
170,073
103,636
136,570
182,157
206,284
98,314
129,853
161,367
186,516
97,213
122,301
147,219
109,895
28,636
43,506
112,246
129,433
91,721
108,081
125,260
134,492
87,113
106,068
126,751
148,515
92,300
118,810
118,81092,300148,515126,751106,06887,113134,492125,260108,08191,721129,433112,24643,50628,636109,895147,219122,30197,213186,516161,367129,85398,314206,284182,157136,570103,636170,073145,204108,22786,89666,755160,181142,812108,49669,894121,41396,56575,106108,05194,48076,54762,058101,16288,75174,91261,45098,92892,927063,90628,0978,021
   Capital Surplus 0000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,479
-4,826
3,258
5,210
2,788
1,294
1,299
-1,354
-4,804
-11,365
-11,365-4,804-1,3541,2991,2942,7885,2103,258-4,8262,479000000000000000000000000000000000000000000



Balance Sheet

Currency in THB. All numbers in thousands.




Cash Flow

Currency in THB. All numbers in thousands.




Income Statement

Currency in THB. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue223,352
Cost of Revenue-46,264
Gross Profit177,088177,088
 
Operating Income (+$)
Gross Profit177,088
Operating Expense-149,532
Operating Income73,82027,556
 
Operating Expense (+$)
Research Development-
Selling General Administrative106,293
Selling And Marketing Expenses-
Operating Expense149,532106,293
 
Net Interest Income (+$)
Interest Income7,622
Interest Expense-864
Net Interest Income6,7586,758
 
Pretax Income (+$)
Operating Income73,820
Net Interest Income6,758
Other Non-Operating Income Expenses-
Income Before Tax (EBT)85,49068,908
EBIT - interestExpense = 72,956
85,490
69,563
Interest Expense864
Earnings Before Interest and Taxes (ebit)73,82086,354
Earnings Before Interest and Taxes (ebitda)113,312
 
After tax Income (+$)
Income Before Tax85,490
Tax Provision-16,791
Net Income From Continuing Ops68,69968,699
Net Income68,699
Net Income Applicable To Common Shares68,699
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-3,025
Total Other Income/Expenses Net4,912-6,758
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
0R40.LSE
23 minutes ago

I found you a Death Cross on the daily chart of 0R40.LSE.

0R40.LSE Daily Candlestick Chart
0QGU.LSE
27 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.LSE.

0QGU.LSE Daily Candlestick Chart
0QHL.LSE
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QHL.LSE.

0QHL.LSE Daily Candlestick Chart
0QGU.IL
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.IL.

0QGU.IL Daily Candlestick Chart
0Q7S.LSE
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0Q7S.LSE.

0Q7S.LSE Daily Candlestick Chart
0O8F.LSE
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0O8F.LSE.

0O8F.LSE Daily Candlestick Chart
0NX0.LSE
33 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0NX0.LSE.

0NX0.LSE Daily Candlestick Chart
0MPM.LSE
40 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 0MPM.LSE.

0MPM.LSE Daily Candlestick Chart
0MPJ.LSE
41 minutes ago

I found you a Golden Cross on the daily chart of 0MPJ.LSE.

0MPJ.LSE Daily Candlestick Chart
0MLH.IL
41 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0MLH.IL.

0MLH.IL Daily Candlestick Chart
0J6X.LSE
47 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 0J6X.LSE.

0J6X.LSE Daily Candlestick Chart
0IXZ.LSE
48 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IXZ.LSE.

0IXZ.LSE Daily Candlestick Chart
0IT3.IL
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IT3.IL.

0IT3.IL Daily Candlestick Chart
0HAH.LSE
52 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0HAH.LSE.

0HAH.LSE Daily Candlestick Chart
0H3T.LSE
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0H3T.LSE.

0H3T.LSE Daily Candlestick Chart
0EEE.LSE
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0EEE.LSE.

0EEE.LSE Daily Candlestick Chart
0FM1.LSE
56 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0FM1.LSE.

0FM1.LSE Daily Candlestick Chart
0DJI.LSE
57 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0DJI.LSE.

0DJI.LSE Daily Candlestick Chart
JSCP.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JSCP.NYSE ARC.

JSCP.NYSE ARC Daily Candlestick Chart
JPMB.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPMB.NYSE ARC.

JPMB.NYSE ARC Daily Candlestick Chart
JPIN.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPIN.NYSE ARC.

JPIN.NYSE ARC Daily Candlestick Chart
JIGB.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JIGB.NYSE ARC.

JIGB.NYSE ARC Daily Candlestick Chart
JHMD.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JHMD.NYSE ARC.

JHMD.NYSE ARC Daily Candlestick Chart
IXUS.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IXUS.NASDAQ.

IXUS.NASDAQ Daily Candlestick Chart
ISWN.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISWN.NYSE ARC.

ISWN.NYSE ARC Daily Candlestick Chart